Table 5:
Distribution of sternal wound infections among the matched controls and the closed-incision negative pressure therapy group
| Control group (n = 766) | ciNPT group (n = 766) | P-value | |
|---|---|---|---|
| Total patients with SWI | 119 (15.5%) | 43 (5.6%) | 0.0001 |
| Superficial SWI | 88 (11.4%) | 29 (3.7%) | 0.0001 |
| Deep SWI | 31 (4.04%) | 14 (1.8%) | 0.0149 |
| SWI classification * | |||
| Type 1A | 63 (8.2%) | 20 (2.6%) | 0.0001 |
| Type 1B | 25 (3.2%) | 9 (1.17%) | 0.0084 |
| Type 2A | 15 (1.9%) | 10 (1.3%) | 0.4206 |
| Type 2B | 6 (0.78%) | 4 (0.52%) | 0.7531 |
| Type 3A | 7 (0.91%) | 0 | 0.0154 |
| Type 3B | 3 (0.39%) | 0 | 0.2495 |
| Treatment administered | |||
| Antibiotics | 119(15.5%) | 43(5.6%) | 0.0001 |
| Debridement | 19(2.5%) | 7(0.91%) | 0.0278 |
| Rewiring | 13(1.7%) | 4(0.52%) | 0.0479 |
| NPWD | 28(3.6%) | 9(1.17%) | 0.0023 |
| Plastic surgical intervention | 7(0.91%) | 0 | 0.0154 |
NPWD: negative pressure wound dressing ; SWI: sternal wound infection .
SWI classification is described in Table 1.